1,720,973 research outputs found
Lysosomal storage diseases - The horizon expands
No full textSince the discovery of the lysosome in 1955, advances have been made in understanding the key roles and functions of this organelle. The concept of lysosomal storage diseases (LSDs) - disorders characterized by aberrant, excessive storage of cellular material in lysosomes - developed following the discovery of α-glucosidase deficiency as the cause of Pompe disease in 1963. Great strides have since been made in understanding the pathobiology of LSDs and the neuronal ceroid lipofuscinoses (NCLs). The NCLs are neurodegenerative disorders that display symptoms of cognitive and motor decline, seizures, blindness, early death, and accumulation of lipofuscin in various cell types, and also show some similarities to 'classic' LSDs. Defective lysosomal storage can occur in many cell types, but the CNS and PNS are particularly vulnerable to LSDs and NCLs, being affected in two-thirds of these disorders. Most LSDs are inherited in an autosomal recessive manner, with the exception of X-linked Hunter disease, Fabry disease and Danon disease, and a variant type of adult NCL (Kuf disease). This Review provides a summary of known LSDs, and the pathways affected in these disorders. Existing therapies and barriers to development of novel and improved treatments for LSDs and NCLs are also discussed. © 2013 Macmillan Publishers Limited.Abbott MA, 2011, MOL GENET METAB, V104, P583, DOI 10.1016-j.ymgme.2011.08.003; Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073-pnas.0712309105; Aliabadi H, 2010, NEUROSURGERY, V67, P1476, DOI 10.1227-NEU.0b013e3181f8c11d; Al Sawaf S, 2008, J INHERIT METAB DIS, V31, P473, DOI 10.1007-s10545-008-0878-x; Alvarez VE, 2012, BBA-PROTEINS PROTEOM, V1824, P195, DOI 10.1016-j.bbapap.2011.05.011; [Anonymous], 2009, SUMM GAUCH DIS PAT P; Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016-j.ajhg.2011.04.004; ARVIO M, 1993, ACTA PAEDIATR, V82, P587, DOI 10.1111-j.1651-2227.1993.tb12761.x; Auffray C, 2011, GENOME MED, V3, DOI 10.1186-gm220; AULA P, 1979, ARCH NEUROL-CHICAGO, V36, P88; Bailey L., 2008, ONLINE J ISSUE UNPUB, V13, P3; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016-j.bbamcr.2008.12.001; B'chir W., NUCL ACIDS RES; Batten FE., 1903, T OPHTHAL SOC UK, V23, P386; Benitez BA, 2011, PLOS ONE, V6, DOI 10.1371-journal.pone.0026741; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016-j.ajhg.2007.12.019; Biegstraaten M, 2012, MOL GENET METAB, V106, P135, DOI 10.1016-j.ymgme.2012.03.010; Bielschowsky M., 1913, DEUTSCHE Z NERVENHEI, V50, P7; Birch DG, 1999, MOL GENET METAB, V66, P356, DOI 10.1006-mgme.1999.2829; Bonten EJ, 2004, FASEB J, V18, P971, DOI 10.1096-fj.03-0941fje; Boustany R. M., 2013, EMERY RIMOINS PRINCI; Boustany R. M., 2007, EMERY RIMOINS PRINCI, P2449; Boustany R M, 1988, Am J Med Genet Suppl, V5, P47; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146-annurev.med.57.110104.115650; BRAMA I, 1986, INT J PEDIATR OTORHI, V11, P229, DOI 10.1016-S0165-5876(86)80034-9; Braunlin EA, 2011, J INHERIT METAB DIS, V34, P1183, DOI 10.1007-s10545-011-9359-8; Brooks DA, 2006, TRENDS MOL MED, V12, P367, DOI 10.1016-j.molmed.2006.06.001; Chang JW, 2011, J NEUROCHEM, V116, P659, DOI 10.1111-j.1471-4159.2010.07158.x; Chattopadhyay S, 2000, J BACTERIOL, V182, P6418, DOI 10.1128-JB.182.22.6418-6423.2000; Chen CS, 1999, LANCET, V354, P901, DOI 10.1016-S0140-6736(98)10034-X; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172-JCI200215420; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016-j.bbapap.2011.03.007; COLLINS RC, 1989, ANN INTERN MED, V110, P992; Coutinho MF, 2012, MOL GENET METAB, V105, P542, DOI 10.1016-j.ymgme.2011.12.012; Crystal RG, 2004, HUM GENE THER, V15, P1131; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159-000328989; d'Azzo A., 2009, NATHAN OSKIS HEMATOL, P1301; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371-journal.pone.0006951; de Ru MH, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186-1750-1172-6-55; Debs R., J INHERIT METAB DIS; DEDUVE C, 1964, FED PROC, V23, P1045; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038-ncb0905-847; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146-annurev-genom-090711-163739; Dhar S, 2002, ANN NEUROL, V51, P448, DOI 10.1002-ana.10143; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002-jnr.21912; Domon MM, 2011, BIOCHEM BIOPH RES CO, V405, P192, DOI 10.1016-j.bbrc.2010.12.138; Eliyahu E, 2011, PLOS ONE, V6, DOI 10.1371-journal.pone.0022447; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007-s10545-007-0521-2; Escolar ML, 2006, PEDIATRICS, V118, pE879, DOI 10.1542-peds.2006-0747; Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056-NEJMoa042604; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056-NEJM200107053450104; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038-nrm1423; Garbutt S, 2000, BRIT J OPHTHALMOL, V84, P451, DOI 10.1136-bjo.84.5.451; Ghosh A, 2012, J BIOL CHEM, V287, P38922, DOI 10.1074-jbc.M112.365148; Ginzburg L, 2005, J NEUROCHEM, V95, P1619, DOI 10.1111-j.1471-4159.2005.03534.x; Ginzburg L, 2008, J NEUROCHEM, V104, P140, DOI 10.1111-j.1471-4159.2007.04983.x; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194-jlr.M600084-JLR200; Goebel HH, 1996, BRAIN PATHOL, V6, P225, DOI 10.1111-j.1750-3639.1996.tb00850.x; Guillemot N, 2007, PEDIATR PULM, V42, P1207, DOI 10.1002-ppul.20725; Guo WX, 1999, CELL MOL NEUROBIOL, V19, P671, DOI 10.1023-A:1006992704108; Gupta Nidhi, 2012, Saudi J Anaesth, V6, P178, DOI 10.4103-1658-354X.97036; Haddad Saria El, 2012, Electrophoresis, V33, P3798, DOI 10.1002-elps.201200472; Haltia M., BIOCH BIOPHYS ACTA; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126-science.2643164; Harati H., 2012, 13 INT C NEUR CER LI, P54; HERS HG, 1965, GASTROENTEROLOGY, V48, P625; Hirabayashi Y., 2006, SPHINGOLIPID BIOL, P83; Hoffmann B, 2005, NEUROPEDIATRICS, V36, P285, DOI 10.1055-s-2005-872810; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007-400_2009_19; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146-annurev.genom.9.081307.164303; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038-sj.emboj.7600991; Jakobkiewicz-Banecka J, 2009, J BIOMED SCI, V16, DOI 10.1186-1423-0127-16-26; Jansky J., 1908, SB LEK, V13, P165; Jardim LB, 2010, J INHERIT METAB DIS, V33, P315, DOI 10.1007-s10545-010-9079-5; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111-j.1365-2141.2004.05351.x; Johnson GB, 2002, J IMMUNOL, V168, P5233; Jurecka A, 2012, PEDIATR NEUROSURG, V48, P191, DOI 10.1159-000345635; Kamate M, 2011, PEDIATR NEUROL, V44, P155, DOI 10.1016-j.pediatrneurol.2010.09.015; Kanazawa T, 2000, J CELL BIOL, V149, P943, DOI 10.1083-jcb.149.4.943; Khoury M. J., 2013, PUBLIC HLTH GENOMICS; Kim SJ, 2006, HUM MOL GENET, V15, P1580, DOI 10.1093-hmg-ddi078; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093-hmg-ddl105; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038-nature08710; Klenk E., 1939, Z PHYSL CHEM, V262, P128; KOBAYASHI T, 1987, BIOCHEM BIOPH RES CO, V144, P41, DOI 10.1016-S0006-291X(87)80472-2; KOBAYASHI T, 1992, J NEUROCHEM, V59, P1452, DOI 10.1111-j.1471-4159.1992.tb08460.x; Koeberl DD, 2011, MOL GENET METAB, V103, P107, DOI 10.1016-j.ymgme.2011.02.006; Kohan R, 2011, CURR PHARM BIOTECHNO, V12, P867, DOI 1389-2010-11 $58.00+.00; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016-S0002-9440(10)61253-9; Kolodny E., 1983, METABOLIC BASIS INHE, P881; Kolodny E. H., 1987, HEMATOLOGY INFANCY C, P1212; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074-jbc.274.31.21673; Kumperscak HG, 2005, J PSYCHIATR NEUROSCI, V30, P33; Kwon JY, 2011, AM J MED GENET A, V155A, P1329, DOI 10.1002-ajmg.a.34013; Lake BD, 1998, BRAIN PATHOL, V8, P133; Lane SC, 1996, J NEUROCHEM, V67, P677; Lang G. E., 1988, RETINAL DYSTROPHIES, P319; Li ST, 2013, FASEB J, V27, P34, DOI 10.1096-fj.12-207472; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074-jbc.M300212200; te Vruchte Danielle, 2004, J Biol Chem, V279, P26167; Lukina E, 2010, BLOOD, V116, P893, DOI [10.1182-blood-2010-03-273151, 10.1182-blood-2010-06-293902]; Ma XC, 2007, MOL THER, V15, P889, DOI 10.1038-mt.sj.6300112; Maegawa GHB, 2009, MOL GENET METAB, V98, P215, DOI 10.1016-j.ymgme.2009.06.005; Maga JA, 2013, J BIOL CHEM, V288, P1428, DOI 10.1074-jbc.M112.438663; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038-nrm2239; Manara R, 2011, J INHERIT METAB DIS, V34, P763, DOI 10.1007-s10545-011-9317-5; Messinger YH, 2012, GENET MED, V14, P135, DOI 10.1038-gim.2011.4; Miller JN, 2013, HUM MOL GENET, V22, P2723, DOI 10.1093-hmg-ddt120; Mohrenschlager M, 2010, EUR J MED GENET, V53, P225, DOI 10.1016-j.ejmg.2010.02.001; Mole S., 2012, NEURONAL CEROID LIPO; Montano AM, 2008, MOL GENET METAB, V94, P178, DOI 10.1016-j.ymgme.2008.01.007; MOREHEAD JM, 1993, INT J PEDIATR OTORHI, V26, P255, DOI 10.1016-0165-5876(93)90096-L; Muenzer J, 2011, RHEUMATOLOGY, V50, pV4, DOI 10.1093-rheumatology-ker394; Muhlebach MS, 2011, PAEDIATR RESPIR REV, V12, P133, DOI 10.1016-j.prrv.2010.10.005; Muller S, 2012, BBA-PROTEINS PROTEOM, V1824, P34, DOI 10.1016-j.bbapap.2011.07.003; Neto ARD, 2013, J NEUROSURG-PEDIATR, V11, P327, DOI 10.3171-2012.11.PEDS11419; NILSSON O, 1982, BIOCHIM BIOPHYS ACTA, V712, P453, DOI 10.1016-0005-2760(82)90272-7; Pacheco CD, 2007, AUTOPHAGY, V3, P487; Palmucci S., INSIGHTS IMAGING; Pan CD, 2005, BLOOD, V106, P1956, DOI 10.1182-blood-2005-02-0657; Pastores GM, 2007, MOL GENET METAB, V91, P37, DOI 10.1016-j.ymgme.2007.01.011; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016-j.nbd.2004.09.004; Pelled D, 2003, J BIOL CHEM, V278, P29496, DOI 10.1074-jbc.M302964200; Persaud-Sawin DA, 2005, APOPTOSIS, V10, P973, DOI 10.1007-s10495-005-0733-6; Persaud-Sawin DA, 2007, PEDIATR RES, V61, P146, DOI 10.1203-pdr.0b013e31802d8a4a; Persaud-Sawin DANW, 2002, HUM MOL GENET, V11, P2129, DOI 10.1093-hmg-11.18.2129; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111-j.1651-2227.2008.00656.x; Platt FM, 2009, BBA-MOL CELL RES, V1793, P737, DOI 10.1016-j.bbamcr.2008.08.009; Puranam K, 1997, NEUROPEDIATRICS, V28, P37, DOI 10.1055-s-2007-973664; Puranam KL, 1999, MOL GENET METAB, V66, P294, DOI 10.1006-mgme.1999.2834; Raben N, 2007, Acta Myol, V26, P45; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016-j.bbapap.2011.08.016; Rountree JSS, 2009, CHEMMEDCHEM, V4, P378, DOI 10.1002-cmdc.200800350; Rusyn E, 2008, PEDIATR RES, V63, P625, DOI 10.1203-PDR.0b013e31816fdc17; Sachs B., 1896, NEW YORK M J, V63, P697; Saftig P, 2008, AUTOPHAGY, V4, P510; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038-nrm2745; Sands MS, 2006, MOL THER, V13, P839, DOI 10.1016-j.ymthe.2006.01.006; Sarpong A, 2009, CLIN GENET, V76, P38, DOI 10.1111-j.1399-0004.2009.01179.x; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016-j.tins.2011.05.006; Seehafer SS, 2011, J NEUROIMMUNOL, V230, P169, DOI 10.1016-j.jneuroim.2010.08.024; Sehgal R, 2011, NEUROLOGY, V77, pE20, DOI 10.1212-WNL.0b013e318225aaf5; Settembre C, 2008, AUTOPHAGY, V4, P113; Shapiro BE, 2009, GENET MED, V11, P425, DOI 10.1097-GIM.0b013e3181a1b5c5; Shih SL, 2002, ACTA RADIOL, V43, P40, DOI 10.1034-j.1600-0455.2002.430108.x; Siddiqi ZA, 2006, NEUROLOGY, V67, P268, DOI 10.1212-01.wnl.0000230156.01228.33; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073-pnas.0912937107; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016-j.ajhg.2012.04.021; Smith KR, 2013, HUM MOL GENET, V22, P1417, DOI 10.1093-hmg-dds558; Spranger J., 2007, EMERY RIMOINS PRINCI, P2403; Staropoli JF, 2012, AM J HUM GENET, V91, P202, DOI 10.1016-j.ajhg.2012.05.023; Staretz-Chacham O, 2009, PEDIATRICS, V123, P1191, DOI 10.1542-peds.2008-0635; Stengel O. C., 1826, EYR MED TIDSKRIFT, V1, P347; SHAPIRO J, 1985, ANN OTO RHINOL LARYN, V94, P458; Su M., 2013, J ONCOL, V2013, DOI [10.1155-2013-102735, DOI 10.1155-2013-102735]; Sunwoo MK, 2011, J CLIN NEUROL, V7, P99, DOI 10.3988-jcn.2011.7.2.99; Suvarna JC, 2008, J POSTGRAD MED, V54, P54; Suzuki M, 2007, J NEUROSCI, V27, P1879, DOI 10.1523-JNEUROSCI.5282-06.2007; SVENNERHOLM L, 1962, BIOCHEM BIOPH RES CO, V9, P436, DOI 10.1016-0006-291X(62)90030-X; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016-j.molcel.2004.08.029; Thappa DM, 1998, PEDIATR DERMATOL, V15, P370, DOI 10.1046-j.1525-1470.1998.1998015370.x; The International Batten Disease Consortium, 1995, CELL, V82, P949; Tokushige S, 2013, BRAIN DEV-JPN, V35, P579, DOI 10.1016-j.braindev.2012.08.004; Tropak MB, 2010, GLYCOBIOLOGY, V20, P356, DOI 10.1093-glycob-cwp183; Tuttolomondo A., CURR PHARM DES; Urbanelli Lorena, 2013, Recent Pat CNS Drug Discov, V8, P91; Vainio S, 2005, BIOCHEM J, V391, P465, DOI 10.1042-BJ20050460; Valayannopoulos V, 2011, RHEUMATOLOGY, V50, pV49, DOI 10.1093-rheumatology-ker396; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074-jbc.R110.134452; Vogt H., 1909, ARCH KINDERHEILKD, V51, P1; Vogt H., 1905, MSCHR PSYCHIAT NEURO, V19, P161; Walkley SU, 2009, J INHERIT METAB DIS, V32, P181, DOI 10.1007-s10545-008-1040-5; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016-S1084-9521(02)00055-1; Worgall S, 2007, NEUROLOGY, V69, P521, DOI 10.1212-01.wnl.0000267885.47092.40; Xu M, 2012, J BIOL CHEM, V287, DOI 10.1074-jbc.M112.357707; Young-Gqamana B, 2013, PLOS ONE, V8, DOI 10.1371-journal.pone.0057631; Zaka M, 2004, NEUROSCI LETT, V358, P205, DOI 10.1016-j.neulet.2003.12.126; Zhang ZJ, 2001, NAT MED, V7, P478, DOI 10.1038-86554; Zheng Z., FEBS J; Zhou QH, 2012, DRUG METAB DISPOS, V40, P329, DOI 10.1124-dmd.111.0429038171
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Get PDF“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Get PDFWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
Get PDFWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
koamabayili/VECTRON-author-checklist: VECTRON author checklist
No full textWe have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
Author-wise bibliometric analysis based on entropy.
No full textAuthor-wise bibliometric analysis based on entropy.</p
Author Under Sail The Imagination of Jack London, 1893-1902
No full textIn Author Under Sail, Jay Williams offers the first complete literary biography of Jack London as a professional writer engaged in the labor of writing. It examines the authorial imagination in London's work, the use of imagination in both his fiction and nonfiction, and the ways he defined imagination in the creative process in his business dealings with his publishers, editors, and agents. In this first volume of a two-volume biography, Williams traverses the years 1893 to 1902, from London's "Story of a Typhoon" to The People of the Abyss. The Jack London who emerges in the pages of Author Under Sail is a writer whose partnership with publishers, most notably his productive alliance with George Brett of Macmillan, was one of the most formative in American literary history. London pioneered many author models during the heyday of realism and naturalism, blurring the boundaries of these popular genres by focusing on absorption and theatricality and the representation of the seen and unseen. London created an impassioned, sincere, and extremely personal realism unlike that of other American writers of the time. Author Under Sail is a literary tour de force that reveals the full range of London as writer, creative citizen, and entrepreneur at the same time it sheds light on the maverick side of machine-age literature.Intro -- Title Page -- Copyright Page -- Dedication -- Contents -- Acknowledgments -- Introduction -- 1. Spirit Truth -- 2. From Absorption to Theatricality and Back Again -- 3. "I Will Build a New Present" -- 4. Sons as Authors -- 5. Fathers as Publishers -- 6. The Daughter as Author -- 7. Lovers as Authors -- 8. At Sea with the Family -- 9. Yellow News, Yellow Stories -- 10. The Return Home -- Notes -- Bibliography -- Index -- About Jay WilliamsIn Author Under Sail, Jay Williams offers the first complete literary biography of Jack London as a professional writer engaged in the labor of writing. It examines the authorial imagination in London's work, the use of imagination in both his fiction and nonfiction, and the ways he defined imagination in the creative process in his business dealings with his publishers, editors, and agents. In this first volume of a two-volume biography, Williams traverses the years 1893 to 1902, from London's "Story of a Typhoon" to The People of the Abyss. The Jack London who emerges in the pages of Author Under Sail is a writer whose partnership with publishers, most notably his productive alliance with George Brett of Macmillan, was one of the most formative in American literary history. London pioneered many author models during the heyday of realism and naturalism, blurring the boundaries of these popular genres by focusing on absorption and theatricality and the representation of the seen and unseen. London created an impassioned, sincere, and extremely personal realism unlike that of other American writers of the time. Author Under Sail is a literary tour de force that reveals the full range of London as writer, creative citizen, and entrepreneur at the same time it sheds light on the maverick side of machine-age literature.Description based on publisher supplied metadata and other sources.Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, YYYY. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries
- …
